RN7SL761P

Across TCGA pan-cancer cohorts, RN7SL761P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RN7SL761P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RN7SL761P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL761P expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

KIRC, STAD, and LUSC are the cancer types where RN7SL761P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	II,III,IV	0.072	0.810	<.001	78	view →
STAD	OS	Tertile	All	0.061	0.731	<.001	72	view →
LUSC	OS	Tertile	All	0.137	0.764	<.001	72	view →
THCA	DFS	Tertile	All	0.579	0.935	<.001	54	view →
BRCA	OS	Tertile	All	0.131	0.578	.008	48	view →
SARC	DFS	Tertile	All	0.124	0.635	<.001	33	view →
UCEC	DFS	Tertile	All	0.615	0.899	.002	24	view →
ESCA	OS	Tertile	III,IV	1.000	0.372	.036	12	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RN7SL761P–KIRC (OS)

Open the KIRC breakdown →